25H-NBOMe is a synthetic psychedelic substance belonging to the NBOMe class, which are known for their high potency and strong binding affinity to serotonin receptors, particularly the 5-HT2A receptor. It is structurally derived from 2C-H, a phenethylamine compound, and further modified with an N-benzylmethoxy group to increase potency. Although 25H-NBOMe is lesser-known compared to other NBOMe variants like 25I-NBOMe or 25C-NBOMe, it still exhibits potent psychoactive effects and is primarily used in research settings to explore its receptor interactions and subjective effects. It is not approved for human consumption.

• Belongs to the NBOMe class of synthetic psychedelics
  25H-NBOMe is part of the N-(2-methoxybenzyl) phenethylamine group, designed for extremely high potency and low-dose activation of serotonin receptors.

• Derivative of the 2C-H compound
  It originates from 2C-H, a base phenethylamine, but with added molecular structures that dramatically increase psychoactive properties.

• Acts as a potent 5-HT2A receptor agonist
  Its primary action is to stimulate serotonin receptors responsible for visual and cognitive distortions typical of psychedelic experiences.

• Typically active at microgram doses
  Like other NBOMe compounds, 25H-NBOMe is active in sub-milligram quantities (200–1500mcg), making accurate dosing critical.

• Used for psychopharmacological and receptor research
  Due to its potent receptor activity, researchers study it to better understand serotonergic signaling and hallucinogen mechanisms.

• Has no official medical or therapeutic use
  It is not approved by any regulatory body for therapeutic purposes and is sold exclusively for research and analytical study.

25H-NBOMe produces a wide range of psychedelic effects when consumed, though it is not intended for human use. Its effects are primarily visual and cognitive in nature, often accompanied by physical stimulation and shifts in perception. The onset can be quick, and the experience varies based on dosage, route of administration, and individual neurochemistry.

• Strong visual distortions and color enhancements
  Users report intense patterns, fractals, breathing walls, and dynamic color shifts, even at lower doses.

• Altered time perception and spatial awareness
  Time may seem to slow down or speed up, and physical boundaries may feel fluid or distorted.

• Emotional intensification or instability
  Mood swings, feelings of unity, or deep introspection may occur, but can also shift rapidly to anxiety or paranoia.

• Increased sensory input and synesthesia
  Sounds may appear as colors or textures, and normal sensory boundaries may blur or overlap.

• Stimulation and physical restlessness
  25H-NBOMe often results in heightened physical energy, tension in the body, or an urge to move.

• Mental looping or recursive thought patterns
  Thought loops or repetitive cognitive cycles are common at higher doses.

• Possible confusion or dissociation
  Users may lose touch with reality or their identity temporarily, depending on dosage and tolerance.

The legality of 25H-NBOMe varies widely depending on jurisdiction. It is not currently scheduled under international drug control treaties, but many countries and regions have banned or restricted it individually. Buyers must research and understand the local laws that apply to them before purchasing or handling this compound.

• Unscheduled at the international level
  The United Nations has not placed 25H-NBOMe under global control, though that does not mean it is legal everywhere.

• Frequently controlled under analogue or blanket bans
  In the United States and several other countries, NBOMes are considered analogs of scheduled drugs and are restricted under analogue acts.

• Explicitly banned in multiple countries
  Countries like Germany, Sweden, the UK, and Australia have listed NBOMes as controlled substances, often including 25H-NBOMe by name or class.

• Legal ambiguity in some regions
  In certain countries, 25H-NBOMe exists in a grey area, making it important to verify laws before purchase or importation.

• Psycho Plug does not ship to restricted areas
  We encourage customers to ensure legality before ordering and reserve the right to cancel shipments to jurisdictions where the product is banned.

Proper storage of 25H-NBOMe is essential to preserve its chemical integrity, potency, and stability. Because of its high sensitivity to moisture, heat, and light, improper handling can lead to degradation over time. Whether you’re storing it for immediate use in research or long-term analysis, taking appropriate precautions ensures optimal results.

• Store in a cool, dry environment
  Ideal temperature is between 15–25°C (59–77°F). Avoid humid locations such as bathrooms or unventilated storage cabinets.

• Protect from light exposure
  UV and visible light can degrade 25H-NBOMe. Always store it in an amber glass vial, aluminum foil, or a light-proof container.

• Use airtight, chemical-resistant containers
  Store in sealed borosilicate glass vials or HDPE bottles to avoid contamination and oxidation.

• Keep away from moisture
  Desiccants like silica gel packs are recommended in storage areas to maintain dryness.

• Label clearly and securely
  All containers should be clearly marked with the compound name, date received, concentration (if in solution), and hazard labels.

• Avoid storing in food containers or unlabeled bags
  Accidental exposure can be dangerous due to the compound’s extreme potency in microgram doses.

• For solution form, refrigeration may help
  If stored as a liquid solution, keeping it in a refrigerator between 2–8°C extends shelf life and prevents solvent evaporation.

25H-NBOMe is extremely potent and must be measured with precision. It is active in the microgram range, meaning even slight dosing errors can result in overdose or toxic effects. Accurate measurement techniques such as volumetric dosing are essential, and the compound should never be consumed without proper laboratory-grade equipment.

• Threshold dose: 100–250 micrograms (mcg)
  At this level, subtle effects such as mild visuals or mood enhancement may begin.

• Light dose: 250–500 mcg
  Users may experience light visual effects, changes in thought patterns, and stimulation without overwhelming intensity.

• Common dose: 500–1000 mcg
  This range typically results in strong psychedelic effects including deep visuals, altered perception, and emotional shifts.

• High dose: 1000–1500 mcg
  High doses should be avoided without extreme caution. Risks of negative effects, confusion, and physical stress are elevated.

• Never measure by eye
  Due to its potency, visual estimation is extremely dangerous. Always use a precision milligram scale or volumetric method.

• Volumetric dosing is highly recommended
  Dissolving a known amount into a solution (e.g., ethanol) allows accurate measurement using syringes or droppers.

• Pre-dosed blotters provide convenience and safety
  Purchasing lab-prepared blotters ensures controlled and consistent dosages.

While both 25H-NBOMe and LSD are serotonergic psychedelics that primarily act on the 5-HT2A receptor, they differ in chemical structure, duration, intensity, safety profile, and subjective effects. LSD has a long-established history of use, research, and safety, whereas 25H-NBOMe is a relatively newer compound with a narrower safety margin and more intense physical stimulation.

• Duration of effects is shorter with 25H-NBOMe
  LSD typically lasts 8 to 12 hours, while 25H-NBOMe has a shorter window of 4 to 8 hours, depending on the dose and metabolism.

• 25H-NBOMe is more physically stimulating
  Users often report increased heart rate, body tension, and physical restlessness with 25H-NBOMe, while LSD tends to be more balanced between mental and physical effects.

• Potency differs in dosage form and range
  25H-NBOMe is active at microgram levels similar to LSD, but accurate dosing is more dangerous due to its steeper dose-response curve.

• LSD has a longer track record and safety profile
  LSD has been extensively studied for decades, whereas the NBOMe series, including 25H-NBOMe, lacks comprehensive toxicology and clinical research.

• Subjective effects differ in tone and intensity
  LSD is often introspective and spiritual, while 25H-NBOMe leans more toward intense visuals and physical energy.

• Risk of overdose is higher with 25H-NBOMe
  Unlike LSD, which has a wide safety margin, NBOMes have been associated with overdose incidents due to dosing mistakes.

• LSD is more widely accepted for research and therapy
  Clinical studies on LSD for depression and anxiety are ongoing, while 25H-NBOMe is limited strictly to laboratory use.

Standard drug tests used by employers, law enforcement, and probation programs do not typically screen for NBOMe compounds, including 25H-NBOMe. However, it is possible to detect this substance with specialized testing in forensic and toxicological settings. Detection depends on the method used, the time elapsed since use, and the sensitivity of the testing panel.

• Not included in common urine or saliva panels
  Routine drug screens (e.g., 5-panel or 10-panel tests) do not identify NBOMe compounds.

• Specialized laboratory testing is required
  Techniques like gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–tandem mass spectrometry (LC-MS/MS) can detect 25H-NBOMe in blood, urine, or tissue samples.

• Detection windows are relatively short
  The compound is quickly metabolized and may only be present in detectable amounts for 24–72 hours post-exposure.

• Used primarily in forensic investigations
  Toxicology labs in legal or medical cases may test for NBOMes when unexplained symptoms or fatalities are involved.

• Few commercial test kits are available
  At-home or workplace tests do not currently include NBOMe detection, though this may change as awareness increases.

• Hair testing is rare but possible
  Hair analysis can detect long-term use but requires high-end lab services and is seldom applied to NBOMe detection.

We offer 25H-NBOMe in several standardized formats to meet the needs of various research applications. These forms include pre-dosed blotters, pure crystalline powder, and ready-to-use liquid solutions. Each option is designed for accurate measurement, ease of storage, and long-term chemical stability.

• Blotter paper (pre-dosed micrograms per square)
  This is the most common and convenient format. Each blotter contains a precise dose (typically 500mcg–1500mcg) and can be easily labeled and stored.

• Powder (crystalline, high-purity)
  Our powder format allows researchers to create custom concentrations via volumetric dosing. It must be handled with extreme care due to its microgram-level potency.

• Liquid solution (dissolved in ethanol or distilled water)
  This option is ideal for highly accurate titration and microdosing studies. Solutions are shipped in amber glass vials for light protection.

• Each form undergoes batch-specific testing
  We verify purity and consistency using third-party labs for every format to ensure reliability and scientific accuracy.

• Packaging is discreet and chemically stable
  All materials are vacuum-sealed, tamper-evident, and protected from contamination during transit.

• Storage instructions vary slightly by format
  Blotters require cool, dry environments; solutions may benefit from refrigeration; and powders must be kept sealed to prevent oxidation.

25H-NBOMe is not considered safe for human consumption due to its high potency, narrow therapeutic index, and limited toxicological data. It is strictly intended for research purposes and should be handled only by trained individuals using protective measures. Serious adverse effects and fatalities have been reported from misuse or overdose.

• Extremely small dosage threshold increases overdose risk
  Because it is active in microgram quantities, accidental overdosing is easy without precise equipment.

• Can cause cardiovascular and neurological side effects
  Common adverse reactions include elevated heart rate, hypertension, vasoconstriction, agitation, and seizures.

• No medical or therapeutic use approved
  25H-NBOMe has not been evaluated for clinical applications and lacks safety validation for human exposure.

• May lead to psychological distress or psychosis
  Users have reported paranoia, panic attacks, dissociation, and hallucinations that persist beyond the drug’s primary effects.

• Reports of fatalities linked to NBOMe misuse
  Deaths have occurred, particularly when users mistake NBOMe blotters for LSD or ingest unknown doses.

• Must be handled with gloves, mask, and ventilation
  Accidental skin absorption or inhalation poses a risk. Always use lab safety protocols.

• Should only be handled by qualified researchers
  Anyone without training in research chemical safety should avoid contact with this compound.

The label “Not for human consumption” is a critical legal and safety disclaimer found on research chemical packaging, including 25H-NBOMe. It signals that the product is intended solely for scientific, analytical, or forensic applications and must never be used recreationally or experimentally on oneself or others. Misuse can lead to legal consequences and serious health risks.

• Complies with international regulatory guidelines
  Labeling substances this way is required in many regions to ensure legal sale for laboratory use.

• Indicates no FDA or health authority approval
  These chemicals have not passed the safety and efficacy standards needed for human drug designation.

• Protects buyers and vendors legally
  The disclaimer helps establish that the product is not sold or marketed as a consumable substance.

• Helps prevent accidental misuse
  Clear labeling discourages recreational use and reminds researchers of necessary precautions.

• Avoids misinterpretation as supplements or medicines
  It ensures there’s no confusion with nutraceuticals or pharmaceutical products.

• Supports ethical research practices
  Serious researchers understand and respect these warnings as part of professional conduct.

The duration of 25H-NBOMe’s effects is generally shorter than that of classic psychedelics like LSD, but still substantial enough to produce intense psychoactive experiences. Onset typically occurs within the first hour, with a total duration ranging from 4 to 8 hours, followed by a gradual tapering of effects. The timeline can vary depending on dosage, method of administration, and individual metabolism.

• Onset begins within 30 to 60 minutes
  Effects usually start to manifest within the first hour, especially when absorbed sublingually through blotter paper.

• Peak effects occur at 2 to 3 hours
  This is when the intensity of visuals, altered thinking, and emotional response reaches its highest level.

• Total duration lasts 4 to 8 hours
  After the peak, the effects gradually fade over several hours, though stimulation or insomnia may linger longer.

• After-effects can continue for several more hours
  Users may experience residual stimulation, mental fog, or fatigue after the primary effects subside.

• Higher doses may prolong the experience
  Doses over 1000 mcg may extend the duration of effects and increase the risk of adverse symptoms.

• Route of administration influences onset and duration
  Sublingual or buccal absorption leads to faster onset than nasal insufflation or other uncommon routes.

• Clear-headedness usually returns within 10–12 hours
  By this time, most users report full cognitive and physical recovery, barring any lingering anxiety or fatigue.

Yes, 25H-NBOMe is associated with a range of side effects, particularly when used in uncontrolled or unresearched settings. These can be physical, psychological, or both. The severity and frequency of side effects depend on the dose, individual tolerance, environment, and co-ingestion with other substances. While some side effects are manageable, others may require immediate medical attention.

• Cardiovascular stress such as increased heart rate and blood pressure
  One of the most consistently reported physical effects, which can become dangerous at high doses.

• Peripheral vasoconstriction and cold extremities
  Some users experience numb fingers, poor circulation, or a bluish tint in the limbs during the experience.

• Nausea, dry mouth, and gastrointestinal discomfort
  These are common in the early stages, especially during peak stimulation.

• Headaches or muscle tension
  Prolonged tension in the jaw, shoulders, or neck can occur during intense experiences or after the trip.

• Anxiety, paranoia, or panic attacks
  Psychological distress is more likely at higher doses or in overstimulating environments.

• Insomnia or restlessness following the experience
  Even after the main effects subside, users may feel mentally overstimulated for several hours.

• In rare cases: seizures, hallucination persisting perception disorder (HPPD), or death
  While rare, severe reactions have been reported, particularly when large doses or unsafe combinations are involved.

Yes, like other serotonergic psychedelics, 25H-NBOMe induces tolerance rapidly. This means that repeated use over short periods leads to significantly reduced effects. The body adapts to the stimulation of serotonin receptors, requiring higher doses for the same experience—a risky and dangerous behavior with a compound as potent as 25H-NBOMe.

• Acute tolerance develops after just one use
  A second dose within 24–48 hours will likely have minimal or no effect, even at the same dose.

• Tolerance is temporary and typically resets after 7–10 days
  Waiting this period allows receptor sensitivity to return to baseline levels.

• Cross-tolerance occurs with other psychedelics
  Compounds like LSD, psilocybin, and mescaline may be less effective after recent 25H-NBOMe use.

• Frequent use increases psychological and physical risks
  Attempting to bypass tolerance by increasing the dose can lead to severe side effects or overdose.

• Receptor downregulation may impair serotonin signaling
  Continued overuse may contribute to neurochemical imbalance or affect emotional stability.

• Safe research practice discourages repeated short-term exposure
  For accurate study, spacing out sessions prevents skewed results due to tolerance effects.

Current evidence suggests that 25H-NBOMe does not produce physical dependence or withdrawal symptoms like opioids or stimulants. However, psychological dependence is possible, especially in individuals who misuse it for recreational or escapist reasons. Given the intense nature of its effects and the risks involved, it’s not a substance suited for habitual or frequent use.

• No known physical addiction or withdrawal
  The body does not become chemically dependent on 25H-NBOMe in the way it might with alcohol or benzodiazepines.

• Potential for psychological dependence
  Individuals may become mentally reliant on the experiences or emotional escape it provides.

• Low abuse potential under controlled research use
  When used responsibly in a lab context, the risk of addictive behavior is minimal.

• Lack of euphoria reduces reinforcement behavior
  Unlike addictive drugs, 25H-NBOMe is not associated with feelings of physical pleasure or reward.

• High intensity and side effects deter frequent use
  Its long duration and challenging effects naturally discourage back-to-back sessions.

• Risk increases when used for escapism or self-medication
  Individuals with underlying mental health conditions may misuse it to avoid emotional distress.

Due to its potent nature, 25H-NBOMe should not be handled by anyone lacking proper training, equipment, or understanding of its risks. Certain individuals, based on health, age, or psychological condition, are at especially high risk of adverse effects and should avoid this substance entirely.

• Individuals with cardiovascular conditions
  The stimulant and vasoconstrictive effects can dangerously raise heart rate or blood pressure.

• Those with a history of mental illness
  Conditions like schizophrenia, bipolar disorder, or severe anxiety can be worsened by 5-HT2A agonists.

• Pregnant or breastfeeding individuals
  The effects of 25H-NBOMe on fetal development are unknown, and exposure during pregnancy should be avoided.

• People lacking lab safety knowledge
  Accurate dosing and safe handling require knowledge of volumetric measurement and chemical hygiene.

• Anyone expecting a recreational or therapeutic effect
  This compound is strictly for research, not for emotional healing or consciousness exploration.

• Minors and unlicensed individuals
  The compound should only be accessed by adults with clear legal permission and scientific purpose.

• Users of medications that affect serotonin or cardiovascular systems
  Interactions may cause serotonin syndrome or other dangerous complications.